Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Department of Pathology, City of Hope Comprehensive Cancer Center, Duarte, California, USA.
J Invest Dermatol. 2021 Feb;141(2):295-307.e13. doi: 10.1016/j.jid.2020.05.116. Epub 2020 Jul 8.
Squamous cell carcinoma in situ (SCCIS) is a prevalent precancerous lesion that can progress to cutaneous squamous cell carcinoma. Although SCCIS is common, its pathogenesis remains poorly understood. To better understand SCCIS development, we performed laser captured microdissection of human SCCIS and the adjacent epidermis to isolate genomic DNA and RNA for next-generation sequencing. Whole-exome sequencing identified UV-signature mutations in multiple genes, including NOTCH1-3 in the epidermis and SCCIS and oncogenic TP53 mutations in SCCIS. Gene families, including SLFN genes, contained UV/oxidative-signature disruptive epidermal mutations that manifested positive selection in SCCIS. The frequency and distribution of NOTCH and TP53 mutations indicate that NOTCH mutations may precede TP53 mutations. RNA sequencing identified 1,166 differentially expressed genes; the top five enriched gene ontology biological processes included (i) immune response, (ii) epidermal development, (iii) protein phosphorylation, (iv) regulation of catalytic activity, and (v) cytoskeletal regulation. The NEURL1 ubiquitin ligase, which targets Notch ligands for degradation, was upregulated in SCCIS. NEURL1 protein was found to be elevated in SCCIS suggesting that increased levels could represent a mechanism for downregulating Notch during UV-induced carcinogenesis. The data from DNA and RNA sequencing of epidermis and SCCIS provide insights regarding SCCIS formation.
原位鳞状细胞癌(SCCIS)是一种常见的癌前病变,可进展为皮肤鳞状细胞癌。尽管 SCCIS 很常见,但它的发病机制仍不清楚。为了更好地了解 SCCIS 的发展,我们对人 SCCIS 和相邻表皮进行了激光捕获显微解剖,以分离基因组 DNA 和 RNA 进行下一代测序。全外显子组测序在多个基因中发现了 UV -signature 突变,包括表皮和 SCCIS 中的 NOTCH1-3 以及 SCCIS 中的致癌性 TP53 突变。包括 SLFN 基因在内的基因家族含有 UV/氧化-signature 破坏性表皮突变,这些突变在 SCCIS 中表现出正选择。NOTCH 和 TP53 突变的频率和分布表明,NOTCH 突变可能先于 TP53 突变。RNA 测序鉴定出 1166 个差异表达基因;前五个富集的基因本体生物学过程包括(i)免疫反应,(ii)表皮发育,(iii)蛋白质磷酸化,(iv)催化活性调节和(v)细胞骨架调节。NEURL1 泛素连接酶,可靶向 Notch 配体进行降解,在 SCCIS 中上调。发现 SCCIS 中 NEURL1 蛋白升高,表明水平升高可能是在 UV 诱导的致癌过程中下调 Notch 的一种机制。表皮和 SCCIS 的 DNA 和 RNA 测序数据提供了有关 SCCIS 形成的见解。